Balchem (BCPC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
Meeting called to order by the Chairman, President, and CEO, welcoming shareholders to a virtual format with real-time voting and Q&A capabilities.
Shareholders could vote online using a control number, and polls were opened at the start of the meeting.
Board and executive committee updates
Directors present included the Lead Director and several board members, along with the CFO and Chief Legal Officer.
Independent auditors from RSM US LLP participated in the meeting.
Shareholder proposals
Three management proposals were presented: election of two directors, ratification of the independent auditor, and an advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Balchem
- Record Q2 2026 sales, earnings, and cash flow with robust growth and expanded credit facility.BCPC
Q2 2026 - Record Q1 2026 sales, earnings, and cash flow with growth across all segments and improved margins.BCPC
Q1 2026 - Virtual meeting to vote on directors, auditor, and executive pay set for June 18, 2026.BCPC
Proxy filing - Strong 2025 results, board elections, auditor ratification, and performance-based executive pay.BCPC
Proxy filing - Record sales, earnings, and cash flow growth, with increased dividends and strong global expansion.BCPC
Q4 2025 - Q3 2024 net earnings rose 16.4% on 4.3% higher sales, led by Human Nutrition & Health.BCPC
Q3 2024 - Record Q2 earnings and margin gains led by Human Nutrition & Health and Specialty Products.BCPC
Q2 2024 - Record Q1 sales, double-digit profit growth, and margin expansion across all segments.BCPC
Q1 2025 - Record sales, profit, and cash flow growth, with strong innovation and sustainability progress.BCPC
Q4 2024